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Introduction
Platelet activating factor (PAF) induces vascular barrier
breakdown and intestinal failure that contribute to the
development of sepsis. The exact cellular mechanisms are
not well understood.
Objectives
We aim to analyse the role of cAMP in PAF-induced
intestinal endo- and epithelial dysfunction.
Methods
An isolated model of the rat small bowel (1) was used.
Intestines were stimulated with a 0.5 nmol PAF bolus via
the mesenteric artery alone (PAF, n=5) or after pretreat-
ment with IBMX (100µM) and forskolin (0.5µM) for 20
min (PAF+PDE/AC, n=4) to increase intracellular cAMP
by inhibition of phosphodiesterase (PDE) and stimulation
of adenylate cyclase (AC). The pressure responses, the
vascular fluid loss and the transfer of FITC-labeled vascu-
lar dextran were monitored. cAMP was measured in PAF
stimulated and untreated intestines (n=5) 3 min after
PAF-stimulation or at the equivalent time point.
Results
The maximal pressure amplitude (ΔPmax), the time delay
to achieve ΔPmax (tdΔPmax), the vascular volume loss
(Vloss) as well as the macromolecule transfer to the lymph
(FITClym) and to the lumen (FITClum) were reduced sig-
nificantly by inibition of PDE and stimulation of AC
[Table 1].
Conclusions
While drugs that increase the intracellular cAMP concen-
tration protect the intestine from PAF-induced endo- and
epithelial dysfunction, all the cellular effects of PAF can
not be explained by a deprivation of cAMP in the
intestine.
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Table 1
PAF PAF+PDE/AC
ΔPmax (mmHg) 30.2±4.0 14.7±1.4 p<0.05
tdΔPmax (min) 1.45±0.15 0.77±0.11 p<0.05
Vloss (ml) 19.2±5.7 3.6±0.7 p<0.05
FITClym (mg/15min/g Ψ ) 0.407±0.078 0.026±0.011 p<0.05
FITClum (mg/15min/g Ψ ) 0.671±0.169 0.013±0.010 p<0.05
Ψ , dry weight
cAMP levels in control and PAF treated intestines were comparable
(cAMPCON 4.99±1.76 nM vs cAMPPAF 4.98±0.88 nM, p>0.1).
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